ADHD

by King’s College London edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Sleeping child with trigeminal nerve stimulation device. Credit: Astrid Perez A large multicenter clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD

by Washington University in St. Louis edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes WashU Medicine pediatric neurologist Benjamin Kay, MD, Ph.D., treats children with ADHD. A new study by Kay and colleagues found that stimulant medications commonly prescribed for the condition might mask sleep deprivation by mimicking the effect of good sleep. Credit: Matt Miller/WashU

The most comprehensive review to date of ADHD treatments has found that medication for children and adults, and cognitive behavioural therapy for adults, remain the most effective approaches, backed by the strongest short-term trial evidence. Pills – illustrative photo. Image credit: Pixabay (Free Pixabay license) Researchers led by the Université Paris Nanterre (France), Institut Robert-Debré du Cerveau

by European College of Neuropsychopharmacology edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes Credit: Pixabay/CC0 Public Domain Scientists have found that ADHD (Attention-Deficit/Hyperactivity Disorder) in women is diagnosed approximately five years later than in men, despite symptoms appearing at the same age. Women with ADHD also suffer greater emotional and functional difficulties than men. This work